质子泵抑制剂的心血管风险
Cardiovascular Risk of Proton Pump Inhibitors.
作者信息
Ariel Hannah, Cooke John P
机构信息
HOUSTON METHODIST RESEARCH INSTITUTE, HOUSTON METHODIST HOSPITAL, HOUSTON, TEXAS.
出版信息
Methodist Debakey Cardiovasc J. 2019 Jul-Sep;15(3):214-219. doi: 10.14797/mdcj-15-3-214.
Abstract
Proton pump inhibitors (PPIs) are effective agents for the treatment of gastroesophageal reflux (GERD). However, these drugs have not been approved for long-term use. Now sold over the counter, these agents are being used chronically for GERD without medical supervision. The long-term use of PPIs may have significant adverse effects, in part mediated by their effect of accelerating vascular aging. Physicians should assist patients in tapering off their use of PPIs and replacing them with lifestyle modifications and/or other agents that have better long-term safety profiles.
摘要
质子泵抑制剂（PPIs）是治疗胃食管反流病（GERD）的有效药物。然而，这些药物尚未被批准用于长期使用。现在这些药物可在柜台购买，正被患者在无医学监督的情况下长期用于治疗GERD。长期使用PPIs可能会产生重大不良反应，部分是由其加速血管老化的作用介导的。医生应协助患者逐渐减少PPIs的使用，并代之以生活方式的改变和/或其他具有更好长期安全性的药物。
相似文献
1
Cardiovascular Risk of Proton Pump Inhibitors.质子泵抑制剂的心血管风险
Methodist Debakey Cardiovasc J. 2019 Jul-Sep;15(3):214-219. doi: 10.14797/mdcj-15-3-214.
2
Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review.质子泵抑制剂治疗儿童胃食管反流病的疗效：系统评价。
Pediatrics. 2011 May;127(5):925-35. doi: 10.1542/peds.2010-2719. Epub 2011 Apr 4.
3
Proton pump inhibitor monotherapy and the risk of cardiovascular events in patients with gastro-esophageal reflux disease: a meta-analysis.质子泵抑制剂单药治疗与胃食管反流病患者心血管事件风险：一项荟萃分析
Neurogastroenterol Motil. 2017 Feb;29(2). doi: 10.1111/nmo.12926. Epub 2016 Aug 30.
4
Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo wireless esophageal pH monitoring study.用于Bravo无线食管pH监测研究的停用质子泵抑制剂患者的胃食管反流病相关症状复发情况
Rev Gastroenterol Mex. 2017 Oct-Dec;82(4):277-286. doi: 10.1016/j.rgmx.2016.12.007. Epub 2017 Apr 3.
5
What are the risks of long-term PPI use for GERD symptoms in patients > 65 years?65岁以上患者长期使用质子泵抑制剂治疗胃食管反流病症状有哪些风险？
J Fam Pract. 2019 Apr;68(3):E18-E19.
6
Guidance on the use of over-the-counter proton pump inhibitors for the treatment of GERD.非处方质子泵抑制剂治疗 GERD 的使用指南。
Int J Clin Pharm. 2011 Jun;33(3):493-500. doi: 10.1007/s11096-011-9489-y. Epub 2011 Apr 7.
7
The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.质子泵抑制剂长期使用的风险和益处：美国胃肠病学会的专家评论和最佳实践建议。
Gastroenterology. 2017 Mar;152(4):706-715. doi: 10.1053/j.gastro.2017.01.031.
8
Cardiovascular and non-cardiovascular concerns with proton pump inhibitors: Are they safe?质子泵抑制剂的心血管和非心血管问题：它们安全吗？
Trends Cardiovasc Med. 2019 Aug;29(6):353-360. doi: 10.1016/j.tcm.2018.10.008. Epub 2018 Oct 21.
9
Prospective Study of Gastroesophageal Reflux, Use of Proton Pump Inhibitors and H2-Receptor Antagonists, and Risk of Hearing Loss.胃食管反流、质子泵抑制剂和H2受体拮抗剂的使用与听力损失风险的前瞻性研究
Ear Hear. 2017 Jan/Feb;38(1):21-27. doi: 10.1097/AUD.0000000000000347.
10
ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.小儿胃食管反流病的抗分泌治疗——一项系统评价
Arq Gastroenterol. 2017 Dec;54(4):271-280. doi: 10.1590/S0004-2803.201700000-42. Epub 2017 Sep 21.
引用本文的文献
1
Five-year clinical outcomes of RefluxStop surgery in the treatment of acid reflux: a prospective multicenter trial of safety and effectiveness.反流停止手术治疗胃酸反流的五年临床结果：一项关于安全性和有效性的前瞻性多中心试验
Surg Endosc. 2025 Jul 22. doi: 10.1007/s00464-025-11979-9.
2
A Novel Approach to Gastrointestinal Bleeding Risk Stratification and Proton Pump Inhibitor Effectiveness in Patients with Acute Coronary Syndrome on Dual Antiplatelet Therapy: A Nationwide Retrospective Cohort Study.一种针对接受双联抗血小板治疗的急性冠脉综合征患者胃肠道出血风险分层及质子泵抑制剂疗效的新方法：一项全国性回顾性队列研究。
Cardiovasc Drugs Ther. 2025 Apr 26. doi: 10.1007/s10557-025-07702-4.
3
Risk of stroke associated with proton pump inhibitor use among individuals with and without pre-existing cardiovascular diseases: a systematic review and meta-analysis.患有和未患有心血管疾病的个体使用质子泵抑制剂与中风风险的关系：一项系统评价和荟萃分析。
J Cardiothorac Surg. 2025 Jan 29;20(1):107. doi: 10.1186/s13019-024-03161-4.
4
Proton Pump Inhibitor Use and Incident Cardiovascular Disease in Older Postmenopausal Women.老年绝经后女性使用质子泵抑制剂与心血管疾病的发生
J Am Geriatr Soc. 2025 Feb;73(2):411-421. doi: 10.1111/jgs.19326. Epub 2024 Dec 31.
5
Unsupervised Feature Selection to Identify Important ICD-10 and ATC Codes for Machine Learning on a Cohort of Patients With Coronary Heart Disease: Retrospective Study.无监督特征选择以识别冠心病患者队列机器学习中的重要国际疾病分类第十版（ICD - 10）和解剖治疗化学分类系统（ATC）编码：回顾性研究
JMIR Med Inform. 2024 Jul 26;12:e52896. doi: 10.2196/52896.
6
Long-Term Use of Proton-Pump Inhibitors: Unravelling the Safety Puzzle.质子泵抑制剂的长期使用：解开安全谜题
Cureus. 2024 Jan 23;16(1):e52773. doi: 10.7759/cureus.52773. eCollection 2024 Jan.
7
Osseous implications of proton pump inhibitor therapy: An umbrella review.质子泵抑制剂治疗的骨相关影响：一项伞状综述。
Bone Rep. 2024 Feb 1;20:101741. doi: 10.1016/j.bonr.2024.101741. eCollection 2024 Mar.
8
Association between the Use of Proton Pump Inhibitors and Cardiovascular Diseases: A Nested Case-Control Study Using a National Health Screening Cohort.质子泵抑制剂的使用与心血管疾病之间的关联：一项基于全国健康筛查队列的巢式病例对照研究。
Biomedicines. 2024 Jan 12;12(1):170. doi: 10.3390/biomedicines12010170.
9
Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease.质子泵抑制剂在系统性硬化症中的应用：优化胃食管反流病治疗的重新评估
Lancet Rheumatol. 2022 Nov;4(11):e795-e803. doi: 10.1016/S2665-9913(22)00183-7. Epub 2022 Jul 25.
10
Pharmacokinetics of Antibacterial Agents in the Elderly: The Body of Evidence.老年人抗菌药物的药代动力学：证据主体
Biomedicines. 2023 Jun 4;11(6):1633. doi: 10.3390/biomedicines11061633.
本文引用的文献
1
Strategies for Effective Discontinuation of Proton Pump Inhibitors.有效停用质子泵抑制剂的策略
Curr Gastroenterol Rep. 2018 May 16;20(6):27. doi: 10.1007/s11894-018-0632-y.
2
Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans.质子泵抑制剂使用者的死亡风险：一项针对美国退伍军人的纵向观察队列研究。
BMJ Open. 2017 Jul 4;7(6):e015735. doi: 10.1136/bmjopen-2016-015735.
3
Associations of Acid Suppressive Therapy With Cardiac Mortality in Heart Failure Patients.酸抑制疗法与心力衰竭患者心脏死亡率的关联
J Am Heart Assoc. 2017 May 16;6(5):e005110. doi: 10.1161/JAHA.116.005110.
4
Mortality in the United States, 2015.美国2015年的死亡率。
NCHS Data Brief. 2016 Dec(267):1-8.
5
Proton Pump Inhibitors Accelerate Endothelial Senescence.质子泵抑制剂加速内皮细胞衰老。
Circ Res. 2016 Jun 10;118(12):e36-42. doi: 10.1161/CIRCRESAHA.116.308807. Epub 2016 May 10.
6
Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis.质子泵抑制剂与痴呆风险的关联：基于药物流行病学索赔数据分析。
JAMA Neurol. 2016 Apr;73(4):410-6. doi: 10.1001/jamaneurol.2015.4791.
7
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.质子泵抑制剂的使用与慢性肾脏病风险
JAMA Intern Med. 2016 Feb;176(2):238-46. doi: 10.1001/jamainternmed.2015.7193.
8
Incidence of cardiovascular events and gastrointestinal bleeding in patients receiving clopidogrel with and without proton pump inhibitors: an updated meta-analysis.接受氯吡格雷治疗的患者使用和不使用质子泵抑制剂时心血管事件及胃肠道出血的发生率：一项更新的荟萃分析。
Open Heart. 2015 Jun 30;2(1):e000248. doi: 10.1136/openhrt-2015-000248. eCollection 2015.
9
Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population.质子泵抑制剂的使用与普通人群心肌梗死风险
PLoS One. 2015 Jun 10;10(6):e0124653. doi: 10.1371/journal.pone.0124653. eCollection 2015.
10
Conflicting results between randomized trials and observational studies on the impact of proton pump inhibitors on cardiovascular events when coadministered with dual antiplatelet therapy: systematic review.关于质子泵抑制剂与双重抗血小板疗法合用时对心血管事件影响的随机试验和观察性研究结果相互矛盾：系统评价
Circ Cardiovasc Qual Outcomes. 2015 Jan;8(1):47-55. doi: 10.1161/CIRCOUTCOMES.114.001177. Epub 2015 Jan 13.
Zotero 插件